Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate target site concentrations derived from their established human pharmacokinetics
about
Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate target site concentrations derived from their established human pharmacokinetics
description
scientific article published on 22 April 2020
@en
name
Prioritisation of potential an ...... blished human pharmacokinetics
@en
type
label
Prioritisation of potential an ...... blished human pharmacokinetics
@en
prefLabel
Prioritisation of potential an ...... blished human pharmacokinetics
@en
P2093
P50
P1476
Prioritisation of potential an ...... blished human pharmacokinetics
@en
P2093
Anthony Valentijn
Christopher David
David J Back
Henry Pertinez
Joanne Sharp
Lee Tatham
Patrick G Bray
Paul O'Neill
Stephen A Ward
P2536
P356
10.1101/2020.04.16.20068379
P50
P577
2020-04-22T00:00:00Z
P6179
1126895757